GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Ending Cash Position

BioRegenx (BioRegenx) Ending Cash Position : $0.11 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is BioRegenx Ending Cash Position?

BioRegenx's Ending Cash Position for the quarter that ended in Mar. 2024 was $0.11 Mil.

BioRegenx's quarterly Ending Cash Position declined from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then increased from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($0.11 Mil).

BioRegenx's annual Ending Cash Position declined from Dec. 2021 ($0.02 Mil) to Dec. 2022 ($0.00 Mil) and declined from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).


BioRegenx Ending Cash Position Historical Data

The historical data trend for BioRegenx's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx Ending Cash Position Chart

BioRegenx Annual Data
Trend Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.09 0.02 - -

BioRegenx Quarterly Data
Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 - - - 0.11

BioRegenx Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

BioRegenx's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0+0
=0.00

BioRegenx's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.125+-0.011000000000003
=0.11


BioRegenx Ending Cash Position Related Terms

Thank you for viewing the detailed overview of BioRegenx's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


BioRegenx (BioRegenx) Business Description

Traded in Other Exchanges
N/A
Address
5051 Peachtree Corners Circle, No. 200, Peachtree Corners, GA, USA, 30092
Findit Inc owns Findit.com and the Findit App. Findit.com and the Findit App operate as a Social Media Content Management Platform, that includes its own search engine. Members can utilize Findit search to submit URLs they want Findit to index in Findit search results. Nonmembers can come to Findit and enter search queries, Findit returns matching search results from content posted in Findit along with outside web pages that have been submitted.

BioRegenx (BioRegenx) Headlines

From GuruFocus

Findit Featured Member BioRegenx Announces Investor Update

By ACCESSWIRE ACCESSWIRE 07-20-2022